← Back to Search

Advanced Imaging Techniques for Breast Cancer

N/A
Waitlist Available
Led By Abass Alavi, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women recently diagnosed with Breast Cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is investigating whether four different state-of-the-art breast imaging techniques are better than each other at diagnosing breast cancer, and whether they work better together than alone.

Who is the study for?
This trial is for women recently diagnosed with breast cancer who will have surgery at the Hospital of the University of Pennsylvania. It's not for pregnant women, those treated with preoperative therapy for advanced cancer, anyone with MRI contraindications, or a past diagnosis in the same breast within 5 years.Check my eligibility
What is being tested?
The study compares four imaging techniques—MRI, digital mammography (DMAM), ultrasound, and PET scans—to see how well they work together to determine the extent of breast cancer before surgery.See study design
What are the potential side effects?
Potential side effects may include discomfort during procedures, exposure to radiation from DMAM and PET scans which carries a small risk of harmful effects, and possible allergic reactions to contrast materials used in MRI and PET.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been recently diagnosed with breast cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients Diagnosed with Breast CancerExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,688 Total Patients Enrolled
27 Trials studying Breast Cancer
25,960 Patients Enrolled for Breast Cancer
Abass Alavi, MDPrincipal InvestigatorUniversity of Pennsylvania
3 Previous Clinical Trials
777 Total Patients Enrolled

Media Library

MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET) Clinical Trial Eligibility Overview. Trial Name: NCT00367666 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings in this research project for volunteers?

"Unfortunately, this clinical trial is no longer recruiting patients. First posted on March 1st 2002 and last edited February 28th 2022, the study has since ended recruitment. However, there are an abundance of other medical trials currently engaging in participant enrolment - 2602 to be precise!"

Answered by AI

Is there eligibility criteria to join this experiment?

"Up to 400 individuals aged between 18 and 80, who have been recently diagnosed with breast cancer, are eligible for this study. To be accepted into the trial they must also meet additional requirements such as being treated at an affiliated hospital of the University of Pennsylvania post-study."

Answered by AI

Does this clinical research include an elderly population?

"According to the qualifications for participation in this clinical trial, candidates must be between 18 and 80. For those under 18 years of age there are 74 trials available; conversely, 2507 studies exist for seniors above 65."

Answered by AI
~14 spots leftby Mar 2025